Bone density and lupus kidney activity study
Part of Bones, joints & muscles, Immune system & allergy, Kidney & urinary clinical trials.
This study looks at how lupus kidney disease activity relates to bone mineral density. It may help understand if bone loss is linked to kidney inflammation in lupus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must have lupus nephritis (lupus affecting your kidneys) as defined by your doctor.
- You must have active lupus nephritis symptoms.
- You must be willing to participate and give consent.
- You cannot have end-stage kidney disease requiring dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and urine markers that may show how active lupus kidney disease is and how it changes over time. It may help doctors better monitor people with active lupus-related kidney inflammation.
This study looks at whether a specific antibody (anti-alpha-actinin) in the blood is linked to active lupus kidney disease. It may help doctors better understand and monitor kidney problems in people with lupus.
This study looks at bone density in children with lupus (SLE) and how it's related to their disease symptoms. It may help doctors understand and manage bone health better.
This study is looking for biomarkers (clues in your blood, urine, or tissue) that can help predict how well lupus nephritis (kidney inflammation caused by lupus) responds to treatment. It focuses on people who have active kidney disease and are either starting treatment or have been on a stable treatment for at least a month.
This study looks at a simple urine test to see if it can show how active lupus nephritis (kidney inflammation caused by lupus) is. It might help doctors monitor the condition without needing repeated biopsies.
This trial uses an ultrasound to measure kidney blood flow in people with lupus kidney disease. The goal is to see if this simple test can tell how active the disease is, which might help doctors adjust treatment without needing frequent biopsies.
Hear when a new Bone Mineral Density and Lupus Nephritis Activity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.